Molecular Biology Reports

, Volume 38, Issue 1, pp 219–227

TNF-308 gene polymorphism is associated with COPD risk among Asians: meta-analysis of data for 6,118 subjects

Article

Abstract

Chronic obstructive pulmonary disease (COPD) is a complex polygenic disease in which gene–environment interactions play a critical role in disease onset and progression. The gene encoding tumor necrosis factor (TNF) is one of several candidate loci for the pathogenesis of COPD and is highly polymorphic. A number of studies have investigated the association between the TNF-308 polymorphisms and COPD risk in different populations, and resulted in inconsistent results. A systematic review and meta-analysis of the published studies were performed to gain a clearer understanding of this association. The PubMed, Embase, Web of Science, and CNKI databases were searched for case–control studies published from 1966 to April 2009. Data were extracted and pooled odds ratios (OR) with 95% confidence intervals (CI) were calculated. Twenty-four eligible studies, comprising 2,380 COPD cases and 3,738 controls, were included in the meta-analysis. The pooled result showed that the TNF-308 polymorphisms were significantly associated with an increased risk of COPD (OR = 1.335, 95% CI: 1.172–1.522, for allele A carriers versus G/G; OR = 1.330, 95% CI = 1.174–1.505, for allele A versus allele G). Subgroup analysis supported the results in the Asian populations, but not in the Caucasian populations. When the analysis was limited to only those studies in which the COPD cases and controls were smokers/ex-smokers, the pooled results supported the conclusion. This meta-analysis suggested that the TNF-308 A allele is a more significant risk factor for developing COPD among Asian populations, but not among Caucasians.

Keywords

TNF Polymorphism COPD Meta-analysis 

References

  1. 1.
    Pauwels RA, Buist AS, Calverley PM, Jenkins CR, Hurd SS (2001) Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease. NHLBI/WHO Global Initiative for Chronic Obstructive Lung Disease (GOLD) Workshop summary. Am J Respir Crit Care Med 163:1256–1276. Updated version 2006 is available from URL: http://www.goldcopd.org/
  2. 2.
    Mannino DM, Homa DM, Akinbami LJ, Ford ES, Redd SC (2002) Chronic obstructive pulmonary disease surveillance-United States, 1971–2000. MMWR Surveill Summ 51:1–16Google Scholar
  3. 3.
    Silverman EK (2002) Genetic epidemiology of COPD. Chest 121:1S–6SCrossRefPubMedGoogle Scholar
  4. 4.
    Sandford AJ, Silverman EK (2002) Chronic obstructive pulmonary disease: susceptibility factors for COPD the genotype-environment interaction. Thorax 57:736–741CrossRefPubMedGoogle Scholar
  5. 5.
    Koyama H, Geddes DM (1998) Genes, oxidative stress, and the risk of chronic obstructive pulmonary disease. Thorax 53(Suppl 2):S10–S14CrossRefPubMedGoogle Scholar
  6. 6.
    Molfino NA (2004) Genetics of COPD. Chest 125:1929–1940CrossRefPubMedGoogle Scholar
  7. 7.
    Keatings VM, Collins PD, Scott DM, Barnes PJ (1996) Differences in interleukin-8 and tumor necrosis factor-α in induced sputum from patients with chronic obstructive pulmonary disease or asthma. Am J Respir Crit Care Med 153:530–534PubMedGoogle Scholar
  8. 8.
    Wilson AG, di Giovine FS, Blakemore AIF et al (1992) Single base polymorphism in the human TNFα gene detectable by Nco1 restriction of PCR product. Hum Mol Genet 1:353CrossRefPubMedGoogle Scholar
  9. 9.
    Kroeger KM, Carville KS, Abraham LJ (1997) The -308 tumor necrosis factor-α promoter polymorphism effects transcription. Mol Immunol 34:391–399CrossRefPubMedGoogle Scholar
  10. 10.
    Wilson AG, Symons JA, McDowell TL et al (1997) Effects of a polymorphism in the human tumor necrosis factor-α promoter on transcriptional activation. Proc Natl Acad Sci USA 94:3195–3199CrossRefPubMedGoogle Scholar
  11. 11.
    Brogger J, Steen VM, Eiken HG, Gulsvik A, Bakke P (2006) Genetic association between COPD and polymorphisms in TNF, ADRB2 and EPHX1. Eur Respir J 27:682–688CrossRefPubMedGoogle Scholar
  12. 12.
    Gingo MR, Silveira LJ, Miller YE et al (2008) Tumour necrosis factor gene polymorphisms are associated with COPD. Eur Respir J 31:1005–1012CrossRefPubMedGoogle Scholar
  13. 13.
    Cochran WG (1954) The combination of estimates from different experiments. Biometrics 10:101–129CrossRefGoogle Scholar
  14. 14.
    Mantel N, Haenszel W (1959) Statistical aspects of the analysis of data from retrospective studies of disease. J Natl Cancer Inst 22:719–748PubMedGoogle Scholar
  15. 15.
    DerSimonian R, Laird N (1986) Meta-analysis in clinical trials. Control Clin Trials 7:177–188CrossRefPubMedGoogle Scholar
  16. 16.
    Tobias A (1999) Assessing the influence of a single study in the meta-analysis estimate. Stata Tech Bull 8:15–17Google Scholar
  17. 17.
    Egger M, Davey Smith G, Schneider M, Minder C (1997) Bias in metaanalysis detected by a simple, graphical test. BMJ 315:629–634PubMedGoogle Scholar
  18. 18.
    Jiang P, Li Y (2006) Association among genetic polymorphisms of HO21, TNF2α and chronic obstructive pulmonary disease. J Shangdong Univ 44:1253–1257 (in Chinese)Google Scholar
  19. 19.
    Hsieh MH, Chong IW, Hwang JJ, Lee CH et al (2008) Lack of associations between several polymorphisms in cytokine genes and the risk of chronic obstructive pulmonary diseases in Taiwan. Kaohsiung J Med Sci 24:126–137CrossRefPubMedGoogle Scholar
  20. 20.
    Zhang YQ, Lu BQ (2008) Analysis of TNFA and LTA-gene allele variation in COPD. Chin J Gerontol 19:1909–1911 (in Chinese)Google Scholar
  21. 21.
    Du Y, Sun SM, Li Y (2008) The Relationship between genetic polymorphism of tumor necrosis factor-α, humanβ-defensin-1 and the development of chronic obstructive pulmonary disease. Clinical Medical Journal of China 15:329–331 (in Chinese)Google Scholar
  22. 22.
    Gong Y, Jin ML, Ren T et al (2008) Association of tumor necrosis factor gene promoter polymorphism with chronic obstructive pulmonary disease. Clin Med J China 15:166–169 (in Chinese)Google Scholar
  23. 23.
    Shi YZ, Liu B, Zhang W et al (2007) Association between tumor necrosis factor-α olymorphisms and chronic obstructive pulmonary disease in Heirongjiang province. Chin J Tuberc Respir Dis 30:233–234 (in Chinese)Google Scholar
  24. 24.
    Zhang Y, Wang W, Xu SH et al (2007) Association between polymorphism in the gene coding for tumor necrosis factor-α and chronic obstructive pulmonary disease. J Taishan Med Coll 28:106–109 (in Chinese)Google Scholar
  25. 25.
    Papatheodorou A, Latsi P, Vrettou C et al (2007) Development of a novel microarray methodology for the study of SNPs in the promoter region of the TNF-alpha gene: their association with obstructive pulmonary disease in Greek patients. Clin Biochem 40:843–850CrossRefPubMedGoogle Scholar
  26. 26.
    Broekhuizen R, Grimble RF, Howell WM, Shale DJ, Creutzberg EC, Wouters EF, Schols AM (2005) Pulmonary cachexia, systemic inflammatory profile, and the interleukin 1beta -511 single nucleotide polymorphism. Am J Clin Nutr 82:1059–1064PubMedGoogle Scholar
  27. 27.
    Seifart C, Dempfle A, Plagens A, Seifart U, Clostermann U, Müller B, Vogelmeier C, von Wichert P (2005) TNF-alpha-, TNF-beta-, IL-6-, and IL-10-promoter polymorphisms in patients with chronic obstructive pulmonary disease. Tissue Antigens 65:93–100CrossRefPubMedGoogle Scholar
  28. 28.
    Chierakul N, Wongwisutikul P, Vejbaesya S, Chotvilaiwan K (2005) Tumor necrosis factor-alpha gene promoter polymorphism is not associated with smoking-related COPD in Thailand. Respirology 10:36–39CrossRefPubMedGoogle Scholar
  29. 29.
    Hegab AE, Sakamoto T, Saitoh W et al (2005) Polymorphisms of TNF-α, IL1β, and IL1RN genes in chronic obstructive pulmonary disease. Biochem Biophys Res Commun 329:1246–1252CrossRefPubMedGoogle Scholar
  30. 30.
    Ma ZM, Zhang ZX, Han ZM et al (2005) A study on the relationship between tumor necrosis factor α gene promoter polymorphism and the expressive levels of TNF2α protein. J Clin Intern Med 22:230–232 (in Chinese)Google Scholar
  31. 31.
    Jiang L, He B, Zhao MW, Ning LD, Li XY, Yao WZ (2005) Association of gene polymorphisms of tumour necrosis factor-alpha and interleukin-13 with chronic obstructive pulmonary disease in Han nationality in Beijing. Chin Med J (Engl) 118:541–547Google Scholar
  32. 32.
    Zui FZ, Li Y, Wang L et al (2004) Association between tumor necrosis factor-α olymorphisms and chronic obstructive pulmonary disease [in Chinese]. J Shandong Univ 42:711–720Google Scholar
  33. 33.
    Ma ZM, Zhang ZX, Han ZM et al (2004) A study on relationship between tumor necrosis factor α gene promoter polymorphism and susceptibility to development of COPD. Pract Prev Med 11:417–419 (in Chinese)Google Scholar
  34. 34.
    Ferrarotti I, Zorzetto M, Beccaria M, Gilè LS, Porta R, Ambrosino N, Pignatti PF, Cerveri I, Pozzi E, Luisetti M (2003) Tumour necrosis factor family genes in a phenotype of COPD associated with emphysema. Eur Respir J 21:444–449CrossRefPubMedGoogle Scholar
  35. 35.
    He B, Jiang L, Ning LD et al (2003) Tumor necrosis factor-α gene 308 A allele can predispose to chronic obstructive pulmonary disease in smokers. Chin J Respir Crit Care Med 12:226–229 (in Chinese)Google Scholar
  36. 36.
    Kucukaycan M, Van Krugten M, Pennings HJ, Huizinga TW, Buurman WA, Dentener MA, Wouters EF (2002) Tumor necrosis factor-alpha +489G/A gene polymorphism is associated with chronic obstructive pulmonary disease. Respir Res 3:29CrossRefPubMedGoogle Scholar
  37. 37.
    Sakao S, Tatsumi K, Igari H, Shino Y, Shirasawa H, Kuriyama T (2001) Association of tumor necrosis factor alpha gene promoter polymorphism with the presence of chronic obstructive pulmonary disease. Am J Respir Crit Care Med 163:420–422PubMedGoogle Scholar
  38. 38.
    Higham MA, Pride NB, Alikhan A, Morrell NW (2000) Tumour necrosis factor-alpha gene promoter polymorphism in chronic obstructive pulmonary disease. Eur Respir J 15:281–284CrossRefPubMedGoogle Scholar
  39. 39.
    Keatings V, Cave S, Henry M et al (2000) A polymorphism in the tumor necrosis factor-α gene promoter region may predispose to a poor prognosis in COPD. Chest 118:971–975CrossRefPubMedGoogle Scholar
  40. 40.
    Huang SL, Su CH, Chang SC (1997) Tumor necrosis factor-α gene polymorphism in chronic bronchitis. Am J Respir Crit Care Med 156:1436–1439PubMedGoogle Scholar
  41. 41.
    COPD Branch in Chinese Thoracic Society (2002) The guideline of diagnosis and management for COPD. Chin J Tuberc Respir Dis 25:453–460Google Scholar
  42. 42.
    American Thoracic Society (1995) Standards for the diagnosis and care of patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 152:S77–S120Google Scholar
  43. 43.
    Chinese Thoracic Society (1997) The guideline of diagnosis and management for COPD. Chin J Tuberc Respir Dis 20:199–233Google Scholar
  44. 44.
    British Thoracic Society (1997) BTS guidelines for the management of chronic obstructive pulmonary disease. The COPD Guidelines Group of the Standards of Care Committee of the BTS. Thorax 52(Suppl 15):S1–S28Google Scholar
  45. 45.
    Farber JL (1994) Mechanisms of cell injury by activated oxygen species. Environ Health Perspect 102:17–24CrossRefPubMedGoogle Scholar
  46. 46.
    Rahman I, Swarska E, Henry M, Stolk J, MacNee W (2000) Is there any relationship between plasma antioxidant capacity and lung function in smokers and in patients with chronic obstructive pulmonary disease? Thorax 55:189–193CrossRefPubMedGoogle Scholar
  47. 47.
    Lomas DA, Silverman EK (2001) The genetics of chronic obstructive pulmonary disease. Respir Res 2:20–26CrossRefPubMedGoogle Scholar
  48. 48.
    Hirschhorn JN, Lohmueller K, Byrne E (2002) A comprehensive review of genetic association studies. Genet Med 4:45–61CrossRefPubMedGoogle Scholar
  49. 49.
    Lee YH, Woo J-H, Choi SJ, Ji JD, Song GG (2009) Functional monocyte chemoattractant protein-1 promoter –2518 polymorphism and systemic lupus erythematosus: a meta-analysis. Mol Biol Rep. doi:10.1007/s11033-009-9932-5 Google Scholar
  50. 50.
    Mao C, Pan H, Chen Q, Wang X, Ye D, Qiu L (2010) Association between Fc receptor-like 3 C169T polymorphism and risk of systemic lupus erythematosus: a meta-analysis. Mol Biol Rep 37:191–196CrossRefPubMedGoogle Scholar
  51. 51.
    Ji JD, Lee WJ, Kong KA, Woo JH, Choi SJ, Lee YH, Song GG (2010) Association of STAT4 polymorphism with rheumatoid arthritis and systemic lupus erythematosus: a meta-analysis. Mol Biol Rep 37:141–147CrossRefPubMedGoogle Scholar
  52. 52.
    Yuan H, Pan HF, Li LH, Feng JB, Li WX, Li XP, Ye DQ (2009) Meta analysis on the association between FcgammaRIIa-R/H131 polymorphisms and systemic lupus erythematosus. Mol Biol Rep 36:1053–1058CrossRefPubMedGoogle Scholar
  53. 53.
    Liao R-Y, Mao C, Qiu L-X, Ding H, Chen Q, Pan H-F (2009) TGFBR1*6A/9A polymorphism and cancer risk: a meta-analysis of 13,662 cases and 14,147 controls. Mol Biol Rep. doi:10.1007/s11033-009-9906-7 Google Scholar
  54. 54.
    Li L, Huang X, Huo K (2010) IGFBP3 polymorphisms and risk of cancer: a meta-analysis. Mol Biol Rep 37:127–140CrossRefPubMedGoogle Scholar
  55. 55.
    Zhu W, Wei BB, Shan X, Liu P (2010) 765G>C and 8473T>C polymorphisms of COX-2 and cancer risk: a meta-analysis based on 33 case-control studies. Mol Biol Rep 37:277–288CrossRefPubMedGoogle Scholar
  56. 56.
    Li C, Jiang Z, Liu X (2010) XPD Lys(751)Gln and Asp (312)Asn polymorphisms and bladder cancer risk: a meta-analysis. Mol Biol Rep 37:301–309CrossRefPubMedGoogle Scholar

Copyright information

© Springer Science+Business Media B.V. 2010

Authors and Affiliations

  1. 1.First Department of Respiratory MedicineNanjing Chest HospitalNanjingChina
  2. 2.Department of HematologyThe Affiliated Drum Tower Hospital of Nanjing University School of MedicineNanjingChina
  3. 3.Department of Respiratory Medicine, Jinling HospitalNanjing University School of MedicineNanjingChina
  4. 4.Department of Medical Oncology, Cancer Hospital, Shanghai Medical CollegeFudan UniversityShanghaiChina

Personalised recommendations